High-fat-diet (HFD)-induced obesity is a major contributor to diabetes and cardiovascular disease, but the underlying genetic mechanisms are poorly understood. Here, we use Drosophila to test the hypothesis that HFD-induced obesity and associated cardiac complications have early evolutionary origins involving nutrient-sensing signal transduction pathways. We find that HFD-fed flies exhibit increased triglyceride (TG) fat and alterations in insulin/glucose homeostasis, similar to mammalian responses. A HFD also causes cardiac lipid accumulation, reduced cardiac contractility, conduction blocks, and severe structural pathologies, reminiscent of diabetic cardiomyopathies. Remarkably, these metabolic and cardiotoxic phenotypes elicited by HFD are blocked by inhibiting insulin-TOR signaling. Moreover, reducing insulin-TOR activity (by expressing TSC1-2, 4EBP or FOXO), or increasing lipase expression-only within the myocardium-suffices to efficiently alleviate cardiac fat accumulation and dysfunction induced by HFD. We conclude that deregulation of insulin-TOR signaling due to a HFD is responsible for mediating the detrimental effects on metabolism and heart function.
INTRODUCTION
Obesity has grown to epidemic proportions globally, with more than 1.5 billion adults overweight and 400 million of them considered obese. Increasing evidence indicates that excessive dietary accumulation of lipids (i.e., ''obesity'') is a high risk factor in causing deleterious effects on metabolism and heart function and has been strongly linked to the progression of heart disease and type 2 diabetes (Szendroedi and Roden 2009; van Herpen and Schrauwen-Hinderling 2008) . Investigating the origin and deleterious effects of high-fat-diet (HFD)-induced obesity and its genetic mediators is important in understanding the mechanisms that contribute to obesity-associated secondary diseases, led by heart disease.
However, the mechanisms that underlie HFD pathophysiology have yet to be elucidated and include theories that the cause of obesity is a recent evolutionary genetic adaptation to alternating periods of famine and excess (Neel et al., 1998) . Alternatively, the potential for HFD-induced obesity may have arisen early in evolution via nutrient-sensing pathways that coordinate metabolism. Here, we used the Drosophila model to investigate the genetic mechanisms that may underlie HFD-induced obesity and cardiac dysfunctions. Drosophila is well suited to study this hypothesis. For example, the way the human heart is specified during embryogenesis relies on mechanisms and gene networks that were first elucidated in Drosophila (Bodmer 1995; Harvey 1996) , which has subsequently been validated in many ways in mammals (Cripps and Olson 2002; Zaffran et al., 2002; Ocorr et al., 2007a; Neely et al., 2010) . Not only is the embryology of cardiac specification equivalent between vertebrates and invertebrates, but nearly the entire complement of control genes and interactions is conserved and even partially interchangeable between vertebrates and flies (Bodmer and Venkatesh 1998; Cripps and Olson 2002) . Since there is such a deep evolutionary conservation in the formation of the heart, it is likely that many aspects of heart function are also conserved, including the mechanisms that control or influence how the heart responds to HFD-induced obesity. In addition, Drosophila has already been established as an excellent model for studying the genetic control of metabolism and nutrient-sensing pathways (Baker and Thummel 2007; Leopold and Perrimon 2007; Kim and Rulifson 2004; Oldham and Hafen 2003) . The insulin and TOR pathways are highly conserved regulators in the control of metabolism. Although the molecular basis of regulating and coordinating metabolic homeostasis is far from being understood, manipulating insulin or TOR signaling in species ranging from yeast to humans dramatically influences metabolic responses, such as lipid and glucose homeostasis (Arking et al., 2005; Saltiel and Kahn 2001; Tatar et al., 2003; Vellai et al., 2003; Wang et al., 2005) .
The genetic simplicity of the Drosophila model combined with recently established heart function assays (Ocorr et al., 2007b (Ocorr et al., , 2007c Taghli-Lamallem et al., 2008; Wessells et al., 2004; Fink et al., 2009 ) make it possible to probe the genetic mechanisms of how a HFD affects heart function. Our findings indicate that flies on a HFD become obese, which is dependent on insulin-TOR signaling as well as regulators of lipid metabolisms (triacylglycerol lipase and fatty acid synthase [FAS] ). We show that both systemic and (adipose) tissue-specific manipulations can protect the fly from HFD-induced systemic lipid accumulation and other deleterious effects of high dietary fat, such as heart dysfunction. Moreover, cardiac-specific inhibition of TOR downstream of TSC1-2, overexpression of FOXO, or lipase protects the heart dysfunction in otherwise obese flies due to exposure to HFD conditions. Importantly, our evidence suggests that the metabolic and cardiac dysfunction caused by a HFD is evolutionarily and functionally conserved and mediated by a nutrient-sensitive circuit, which includes insulin-TOR signaling and the control of lipid metabolism. Thus, targeted inhibition of the TOR pathway or lipid biogenesis may provide new therapeutic interventions in obesity and its adverse effects on heart function.
RESULTS

Flies Exhibit Similar Phenotypes as Mammalian Metabolic Syndrome
To investigate the conserved genetic mechanisms involved in lipid accumulation in Drosophila, we first determined the effects of a HFD on the fly's metabolism. We found a dose-dependent increase in whole-body TG content per body mass when flies were fed diets containing 3%-30% saturated fats from coconut oil for 5 days ( Figure 1A , see Figure S1A available online). This indicates that the fly accumulates lipids in a dose-dependent WT flies were used under four different concentrations of saturated fats. At least three independent experiments were done for each time point for all TG experiments. The concentrations used were 3% (n = 46), 7% (n = 49), 15% (n = 31), 30% (n = 81) for 5 days. WT type flies (n = 107) showed a dose-dependent increase in TGs (*p < 0.05, **p < 0.01, ***p < 0.0001).
(B) TG content (expressed as relative change from NF flies) of 10-to 15-day-old females on HFD for 5 days. The w1118 fly strain was used for the wild-type (WT) flies. WT flies were used two different types of saturated fats. Myristic and lauric acid are both the major components of coconut oil. The amount of each fatty acid corresponds to its respective amount found in the 30% HFD. At least three independent experiments were done for each time point for all TG experiments. The concentrations used were lauric acid 14% (n = 36), while myristic acid was 5% (n = 35) and finally 30% of the original coconut oil mixture for 5 days. WT type flies showed an increase in TGs (*p < 0.05, **p < 0.01, ***p < 0.0001).
(C) Glucose content of female WT flies fed a 30% HFD (normalized to WT NF-fed flies of each appropriate age). Trehalose present in the hemolymph was converted to glucose (see the Experimental Procedures). Since 30% HFD gave us the strongest most consistent results, we used 30% for all of the remaining experiments in this study. At least three independent experiments were done for each time point. After 2 days, glucose decreases, then rapidly increases after 5 and 10 days (*p < 0.05, **p < 0.01, ***p < 0.0001). A minimum of 35 flies were used for each variable at each time point. (D) Relative Dilp2 transcript levels in WT flies fed a 30% HFD for 2, 5, and 10 days. Dilp2 levels rapidly increase after 2 days, then begin to decrease the longer the fly remains on a HFD (***p < 0.0001). All qPCR were done in triplicate.
(E) Graphical representation of the effects of HFDinduced obesity on geotaxis. Flies were filmed for 5 s, then the movie was analyzed and individual flies were counted at each height, 1 cm being the lowest portion of the vial with 7 cm being the highest part of the vial. A minimum of 150 flies were used for each variable. All flies eventually moved to the top of the vial, but we only counted the position of the flies to the allotted 5 s time span. Flies on a 30% HFD showed a significant decrease in geotaxic activity, with approximately 80% remaining in the bottom of the vial for the allotted time span. Error bars represent SEM.
fashion. Next, we tested if the major individual fatty acids (FAs) in the coconut oil could also cause an increase in TGs. We found that either lauric or myristic acid (the main components of coconut oil) caused a significant increase in whole body TGs ( Figure 1B, Figure S1B ).
In mammals, increased levels of TGs have been found to be a major risk factor for metabolic syndrome, insulin resistance, and the onset of type 2 diabetes (Ouwens et al., 2005; Van Gaal et al., 2006) . In mammals after initial exposure to HFD, insulin release is increased, which corresponds to a decrease in glucose levels. However, upon chronic exposure to HFD, glucose levels begin to increase as the periphery becomes more insulin resistant. To determine if changes in insulin and glucose homeostasis by HFD-induced obesity are functionally conserved, we tested changes in glucose and insulin homeostasis in flies fed a HFD. Indeed, after 2 days on a 30% HFD, flies showed a decrease in total glucose accompanied by an increase in Drosophila insulin-like peptide 2 (Dilp2) transcript levels ( Figures 1C and  1D ). After 5 and 10 days on HFD, glucose levels rose while Dilp2 levels continued to drop ( Figures 1C and 1D ). Another marker for monitoring insulin-glucose homeostasis is phosphorylated Akt (pAkt), which decreases under HFD conditions, thereby lowering glucose uptake in mammals (Manning, 2004) . In flies on a HFD, pAkt is progressively reduced (Figure S2A ), compared to flies on a normal food (NF) diet. We also find that under a HFD the TOR pathway is activated, as measured by increased 4EBP and S6K phosphorylation ( Figure S2B ). Together, these data suggest that the Drosophila model exhibits central aspects of metabolic syndrome and obesity upon HFD.
Excess dietary fat consumption has been linked with increased nonadipose fat deposition, which is thought to be a contributing factor in instigating several secondary diseases such as type II diabetes, nonalcoholic fatty liver disease, colon cancer, and cardiovascular disease (Schaffer 2003; Unger 2003; van Herpen and Schrauwen-Hinderling 2008) . Therefore we investigated the accumulation of lipids in both adult adipose tissue (fat body, FB) and the midgut, which are the fly's major organs for lipid storage and utilization. Using oil red O to measure the changes in fat accumulation, we find an increase in lipid droplet staining in HFD-treated flies compared to NF fed controls both in FB and gut ( Figure S3 ). These findings indicate that when fed a HFD flies accumulate excess fat in both adipose and nonadipose tissue, as seen in mammals.
A recent study found that upon fat accumulation activity levels tend to decrease (Wareham, 2007) . Therefore, we determined the activity levels of flies under HFD conditions. Normally flies prefer to move against gravity (negatively geotaxic) (Gargano et al., 2005) . When testing for changes in geotaxic activity, we found that HFD-fed flies exhibit a substantial reduction in geotaxic behavior (Movies S1 and S2), with most flies remaining at the bottom of the vial during the experimental time ( Figure 1E ). They will eventually climb to the top, albeit more slowly and less vigorously. These data suggest that consumption of a HFD has adverse, lethargic-like effects on the flies' activity levels.
Increased Dietary Fat Causes Severe Functional and Structural Changes in the Fly Heart
When rodents are fed a HFD, they show signs of increased accumulation of cardiac TGs, accompanied by hypertrophy and decreases in fractional shortening (FS), a relative measure of cardiac contractility (Fang et al., 2008; Sowers, 2003) . It may be the increased adipose and circulating lipid levels that cause a disturbance of cardiac performance. For example, increased expression of lipid transporters in the heart leads to elevated fat in the myocardial cells accompanied by cardiac dysfunction (Chiu et al., 2005) , although the underlying mechanisms have yet to be elucidated. To determine if ''fat'' flies also show increased cardiac TG levels and exhibit deteriorating heart function, we examined them under HFD conditions. After 5 days on a HFD, we observed elevated cardiac TG levels (Figure 2A) and progressively altered contraction patterns ( Figures  2B-2G , Movies S3-S5). We then investigated other cardiac dysfunctions and observed a reduced FS due to a smaller diastolic diameter ( Figures 4C and 4D ), reminiscent of a restrictive cardiac phenotype (see Cammarato et al., 2008) . In addition, we found noncontractile portions of the heart, dysfunctional inflow valves (ostia), and increased incidences of partial conduction blocks (anterior and posterior heart beats at a different rate) (Figures 2D-2G, Movies S6-S8). We also found severe defects and disorganization in the myofibrillar structure of the heart of flies fed a HFD ( Figures 2H1-2H2 00 ). Taken together, these results dramatically illustrate that a HFD in Drosophila adversely affects heart function, and that in both mammals and flies a HFD compromises cardiac activity and structural integrity.
Systemic Inhibition of the TOR Pathway Prevents Excess Fat Accumulation
It is unclear how obesity increases the risk of heart disease. Since the TOR pathway has been linked to nutrient sensing and the modulation of aging heart function in Drosophila (Luong et al., 2006; Wessells et al., 2009 ), we tested whether TOR signaling is involved in the regulation of lipid levels related to cardiac dysfunction. To determine if reducing TOR function can alter the effects of HFD-induced obesity, we fed hypomorphic TOR 7/P mutant flies (Luong et al., 2006) a HFD and observed no increase in TG levels, compared to flies on NF ( Figure 3A ). The TOR mutants show lower TG levels on both NF and a HFD, compared to wild-type on NF ( Figure S1C ). These results suggest that reducing TOR function is either accelerating fat catabolism or decreasing lipid anabolism or storage. To test possible downstream mechanisms that may contribute to this phenotype, we tested the change in transcript levels of genes involved in lipid metabolism: Brummer (ATGL) lipase (Bmm) (Gronke et al., 2005) and fatty acid synthase (FAS) (Valet et al., 2002) . We found that Bmm transcript levels are significantly increased, whereas FAS levels are decreased, in TOR 7/P mutants under both NF and HFD conditions ( Figures 3B and 3C ), suggesting that TOR activity regulates the balance between lipid anabolism and catabolism, possibly due to increased lipase and decreased FAS activity. We tested this idea further by using oil red O, a lipid droplet marker, to investigate the changes in fat accumulation in both the FB and gut. Indeed, HFD-fed TOR mutants showed no increase in the quantity of lipid droplets in both the FB and gut, and fat levels were generally lower ( Figure S3 ).
To determine if TOR-dependent prevention of HFD-induced obesity extends to other HFD-mediated phenotypes, we tested the geotactic activity of the TOR mutants under NF and HFD conditions. We find that in TOR mutants these activity levels are already impaired under NF, and this phenotype is exacerbated when flies are placed on a HFD ( Figure 3D ), which suggests that the protection by the ubiquitous inhibition of TOR activity is not a global response but may be selective to tissue type and lipid metabolism. These data are consistent with mice that are deficient in TOR complex 1 (TORC1) in skeletal muscles, which exhibit a 40% decrease in voluntary wheel activity (Bentzinger et al., 2008) .
Systemic Inhibition of the TOR Pathway Protects the Heart against HFD-Induced Cardiac Dysfunction Next, we tested whether global reduction of TOR function protects the heart's performance under HFD conditions. First, we tested whether the elevated TGs due to a HFD are reduced in the heart itself in TOR 7/P mutants. Indeed, reduced systemic TOR function causes a significant decrease in cardiac TGs, which remains low even under HFD conditions similar to the (D) A sketch of a dissected semi-intact heart preparation. Arrows indicate to the area the corresponding M-modes shown in (E)-(F 0 ).
(E-E 0 ) Representation of partial conduction blocks of hearts using M-modes from different portions of the same heart. (E) M-mode from the anterior portion of the heart displaying a regular heart beat. (E 0 ) M-mode from the posterior portion of the same heart displaying a faster and erratic heart beating pattern, com-
Representation of a portion of the heart that is noncontractile using M-modes of different heart regions. (F) M-mode taken from the anterior portion of the heart displays regular beating pattern. (F 0 ) M-mode taken from the posterior portion of the same heart showing poor or no contractions.
(G) Side bar graph of heart phenotypes seen under HFD conditions with increasing amount of fat. The heart phenotypes used in this graph are partial conduction blocks, noncontractile myocardial cells, dysfunctional ostia, and no noticeable defects. The instances of all three phenotypes increase in a fat-dose-dependent fashion. A minimum of 26 heart movies were analyzed for each dietary condition. , and systemic TSC1-2 overexpression (arm > TSC1-2 flies). At least three independent experiments were performed for each time point for all TG experiments. A significant increase in TGs were seen in WT flies (***p < 0.0001) fed a 30% HFD for 5 days, while TOR mutants (n = 46) started with lower levels of TG under NF, and these levels did not increase even on 30% HFD (n = 48). Arm > TSC flies (n = 30) had similar levels as the WT control flies, but these levels did not increase when placed on a HFD. (B) Relative Bmm (ATGL Lipase) mRNA transcript levels. There is a slight increase in Lipase levels in WT under 30% HFD conditions (p < 0.05). In contrast, TOR 7/P mutants have a 3-fold increase in Bmm levels under NF conditions and remain high under HFD conditions. All qPCRs were done in triplicate.
(C) Expression of FAS transcript levels in WT and TOR 7/P mutants under both NF and 30% HFD conditions for 5 days. 
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A High-Fat Diet Obesity Model in Drosophila results from whole-body TGs (Figure 2A ). We then show that the TOR mutants exhibit considerable protection against deterioration of heart function when placed on a HFD. Remarkably, flies with reduced TOR function exhibit unchanged heartbeat and contractility parameters under NF or HFD, comparable to wildtype under NF conditions ( Figures 4A-4E , Movie S9). Similarly, the incidences of conduction blocks, dysfunctional ostia, and noncontractile myocardial regions were as low as in the TOR mutants under NF or HFD conditions compared to wild-type flies on NF ( Figure 4F ). We also find that the myocardial structure remains intact and similar to WT on NF ( Figures 2H3-2H3  0 ). These findings suggest that a decrease in TOR activity initiates lipid breakdown and decreased lipid synthesis, which may help prevent the adverse effects of a HFD on the heart. Metabolic homeostasis is a balance between storage and expenditure that is regulated by genetic and environmental interactions, both polygenic and multiorgan in nature. To elucidate how reduced TOR signaling alters the HFD response at the tissue level, we used the UAS/Gal4 system (Brand and Perrimon, 1993) to inhibit TOR pathway components both in the (E) Bar graph of systolic diameter of fly heart as in (F) . No decrease in systolic diameter was seen after 5 days on a 30% HFD for any of the strains tested.
(F) Graphical representation of heart phenotypes as in Figure 2G . No significant change to the heart phenotype of TOR 7/P mutants or with systemic TSC1-2 overexpression under HFD could be detected, when compared to WT flies. A minimum of 20 individual fly heart movies were analyzed. Error bars represent SEM.
A High-Fat Diet Obesity Model in Drosophila whole organism and in selective tissues. First, we overexpressed the TOR inhibitor TSC1-2 ubiquitously using the arm-Gal4 driver, which resulted in a similar rescue of the HFD-induced increase in TGs and aberrant heart phenotypes (Figure 4) , as with TOR lossof-function mutants. Moreover, global inhibition of TOR translational effectors (eIf4E and S6K) by 4EBP (Miron et al., 2001) or dominant-negative S6K overexpression (S6K DN ) (Hennig and Neufeld, 2002) , respectively, also elicits a protective cardiac phenotype against HFD-induced abnormalities (data not shown), similar to TSC1-2 overexpression (Figure 4) . These results indicate that systemic inhibition of TOR signaling protects the animal against the adverse cardiac effects of a HFD and that multiple TOR-dependent effectors may contribute to TG accumulation and cardiac dysfunction.
Adipose-Specific Manipulation of Insulin-TOR Signaling Affects Obesity Phenotypes
In insects, the FB is an important organ for lipid storage and hormonal regulation and is functionally comparable to the vertebrate liver and adipose tissue. Therefore, we tested whether inhibition of TOR signaling in the fly's FB can prevent the HFDinduced obesity and heart phenotypes. Expression of TSC1-2, S6K DN , and 4EBP specifically in the FB showed a phenotype similar to the ubiquitous inhibition of TOR exposed to a HFD. Specifically, FB-restricted expression abolished the normally observed increase in TGs, and there are no significant changes in cardiac function of all these genotypes when subjected to HFD conditions ( Figure 5 , Figure S4 ). Thus, genetic manipulations inhibiting TOR pathway activation specifically in the FB resulted in protection from HFD-induced fat accumulation and cardiac dysfunction. This result also suggests that manipulation of TOR in the FB regulates the organism's systemic lipid metabolism, which in turn influences proper heart function.
Since we find that TOR mutants exhibit an increase in Bmm and a decrease in FAS transcript levels ( Figures 3B and 3C) , we tested if expression of Bmm or FAS-RNAi in the FB protects against HFD-induced increases in body fat and heart dysfunction. Indeed, we find that expression of Bmm in the FB prevents systemic TG accumulation and protects against abnormalities in heart function under HFD, similar to FB expression of TSC1-2 ( Figure 5 , Figure S4 ). When we tested the effects of FAS knockdown in the FB, we found a partial decrease in TG levels and a moderate attenuation of HFD-associated heart defects ( Figure 5, Figure S4 ). These findings suggest that prevention of fat accumulation by increasing lipolysis or reducing lipogenesis can mimic the metabolic and cardiac protection from HFD observed by reduced TOR signaling.
It has been shown that loss of insulin signaling in the murine adipose leads to lower circulating insulin levels and prevents obesity (FIRKO mouse; Bluher et al., 2002) . Therefore we tested if altering insulin signaling in the FB had physiological consequences similar to TOR inhibition. To achieve this, we expressed the negative effector of insulin signaling, FOXO, in the FB. This also limited the accumulation of lipids, as we observed for TOR inhibition and Bmm lipase expression, and protected the heart from the adverse effects of excess lipid accumulation ( Figure 5 , Figure S4 ). Thus, reduced insulin-TOR signaling in the FB prevents systemic dyslipidemia and protects the heart (and presumably other organs) from lipid overload.
Autonomous Protection of the Heart from HFD by Cardiac Inhibition of Insulin-TOR Signaling
The above findings raise the question of whether manipulating insulin-TOR signaling in the heart itself is sufficient to protect the heart against the effects of a HFD. To test this, we expressed TSC1-2, 4EBP, and S6K DN specifically in the myocardial cells of the heart and found that the systemic TG levels show the same increase when fed a HFD, as did wild-type flies ( Figure 6A , Figure S5A ). Remarkably, we also observed that myocardial expression of both 4EBP and S6K DN was sufficient to protect against HFD-induced cardiac abnormalities, despite elevated systemic lipid levels ( Figure 6 , Figure S5B ). However, unlike all other TOR inhibitory manipulations, overexpression of TSC1-2 in the heart did not confer a robust protection from a HFDinflicted insult to the heart ( Figure 6 , Figure S5B ). To further confirm that inhibition of TOR itself was sufficient to prevent HFD-induced cardiac dysfunction, we expressed a dominantnegative form of TOR, TOR TED (Hennig and Neufeld, 2002) , in the heart and found similar cardiac protection, as with 4EBP and S6K DN , against the adverse effects of a HFD (Figure 6 ), comparable to the systemic or FB-specific manipulations ( Figure 5 ).
To determine if elevated lipase activity is a possible mechanism downstream of reduced TOR activity in the protection of the heart, we directly expressed the Bmm lipase in the myocardial cells of flies exposed to a HFD. We found that increased cardiac lipase expression protected the hearts against HFDassociated dysfunction, yet the systemic TG levels were increased under a HFD, as in wild-type ( Figure 6A , Figure S5B ). We also tested heart-specific FAS knockdown and observed similar protective phenotypes to those observed with Bmm overexpression or inhibition of TOR signaling downstream of TSC1-2 ( Figure 6, Figure S5B ). These findings strongly imply that reduced cardiac TOR signaling autonomously protects the heart's susceptibility to a HFD by altering lipid metabolism.
Since adipose FOXO expression protects against HFDinduced cardiac malfunction ( Figures 5B and 5C ) and cardiac FOXO expression protects against cardiac aging (Wessells et al., 2004) , we also tested whether FOXO activity in the heart under HFD conditions is also protective. Indeed, we find that the expression of FOXO in myocardial cells autonomously protects the heart from the adverse effects of a HFD, but as expected not against overall body fat accumulation ( Figure 6A ). We then tested if altering downstream insulin-TOR signaling in the heart tissue would affect lipid accumulation with the heart. We found no significant increase in heart-specific TG accumulation in HFD hearts when overexpressing either FOXO or Bmm ( Figure S5C ). We also found that under NF conditions Bmm overexpression had significantly lower levels of heart TGs under NF conditions then WT controls ( Figure S5C ). These findings correlate well with our previous data showing a decrease in TG accumulation when inhibiting insulin-TOR or increasing lipase activity. Taken together, these results suggest that moderate reduction in insulin-TOR signaling prevents HFD-induced obesity and cardiac dysfunction (Figure 7 ). It will be interesting to see whether FOXO acts upstream of TOR effectors (i.e., 4EBP) in protecting the heart from lipotoxicity, as it does in reducing the decline of cardiac performance with age (Wessells et al., 2009 ).
DISCUSSION
HFD-induced obesity is associated with an increased risk for diseases, including cancer, diabetes, and heart disease. The polygenic and/or multiorgan nature of HFD-induced obesity makes it difficult to determine the relative contribution to each of these diseases. In order to examine these complicated interactions in a simple system, we established a HFD-induced obesity model in Drosophila to elucidate the underlying mechanisms. We used the genetic versatility of the Drosophila model along with sophisticated cardiac function assays to investigate the effects of insulin-TOR-mediated metabolic regulation and the crosstalk between organs exposed to excess dietary fat. We find that HFD-fed flies become obese, develop metabolic syndrome, and exhibit severe symptoms of cardiac lipotoxicity. The deleterious HFD-induced effects are alleviated by genetic manipulations of metabolic regulators or by directly altering lipid metabolism either systemically, in adipose tissue, or specifically (autonomously) in the heart.
We provide evidence that Drosophila fed a HFD exhibit central features of mammalian metabolic syndrome, including elevated lipid levels and changes in insulin and glucose homeostasis. Furthermore, the effects of the HFD-induced obesity on the heart are profound, including diminished contractility, conduction blocks, and structural defects. The HFD-induced elevation in TG levels is an important marker for this collection of phenotypes, as high TG levels are associated with disruptions of lipid and glucose homeostasis, mitochondrial function, and other processes (Schaffer 2003; Unger 2003; Ouwens et al., 2005; Van Gaal et al., 2006; van Herpen and Schrauwen-Hinderling 2008) , all of which may contribute to high lipid accumulation and heart phenotypes.
Because the insulin-TOR pathway is a key integrator of metabolism, we initiated a comprehensive investigation of both the systemic and tissue-specific effects of altering insulin-TOR signaling under HFD conditions. We found that reduction of pathway activity blocks HFD-induced increased lipid levels in Drosophila. Recent studies have begun to connect insulin-TOR signaling to the regulation of lipid metabolism in flies and mammals (Luong et al., 2006; Li et al., 2010; Lee et al., 2010; this study) . For example, the increased lipid synthesis caused by insulin treatment is blocked by reduction of TOR function, and the activation of the TOR pathway leads to fat accumulation (Luong et al., 2006; Porstmann et al., 2008; Li et al., 2010) . In addition, TOR function in lipogenesis (and heart function) 
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A High-Fat Diet Obesity Model in Drosophila may be mediated by activation of sterol regulatory element binding protein (SREBP) and its lipogenic target genes, including FAS (H.Y. Lim, R.T.B., S.O., and R.B., unpublished data). Therefore, modulation of lipid metabolism is a likely mechanism that mediates the effect of TOR signaling on the HFD phenotype.
To determine the contributions of lipid metabolism to the HFDinduced obesity phenotypes, we examined a key regulator of lipid utilization: the Bmm (ATGL) gene is required for the breakdown of lipid droplets, and encodes a triacylglycerol lipase that is conserved from nematodes to mammals (Gronke et al., 2005 (Gronke et al., , 2007 this study) . Drosophila Bmm mutants show significant increases in TGs, while ectopic expression results in the reverse effect of lowering TG levels. Previous studies in mice have shown that systemic mutants of ATGL caused increases in lipid accumulation in nonadipose such as the heart (Haemmerle et al., 2006; Hirano et al., 2008) . Here, we find that reduction of TOR function leads to increased Bmm RNA levels and that Bmm overexpression prevents the HFD-induced elevation of TG levels. In the heart, Bmm overexpression protects against cardiac dysfunction and fat accumulation inflicted by a HFD. These protective effects by Bmm may stem from modified lipid utilization by the mitochondria. Additionally, lipid droplet lipolysis may also liberate fatty acid ligands for nuclear receptors, which may contribute to changes in mitochondrial biogenesis (Palanker et al., 2009; Finck et al., 2003) . Altered insulin-TOR signaling is likely to also increase activity of translation factors involved in mitochondrial function (Zid et al., 2009) . Lastly, increases in autophagy have been implicated in the regulation of lipid metabolism via the breakdown of lipid droplets (Kovsan et al., 2009 ). Thus, reduction of insulin-TOR signaling can coordinately lead to changes in lipid metabolism, which in turn affects organismal physiology under excess dietary fat conditions. A critical step in the regulation of lipid synthesis involves SREBP, which in flies responds to decreased levels of the major membrane lipid phosphatidylethanolamine (PE) by increasing FAS expression (Rawson, 2003) . In examining the role of lipid synthesis in relation to the HFD-induced obesity phenotypes, we observed that the transcript levels of FAS decrease in TOR mutants, and that FAS knockdown reduces the deleterious effects of HFD, possibly because of reduced lipid synthesis. Consistent with this idea, loss of SREBP and FAS function in mammalian models leads to low TG levels (Valet et al., 2002; Bentzinger et al., 2008) , and loss of Drosophila easily shocked (eas), which encodes an ethanolamine kinase critical for PE synthesis, leads to increased levels of the active form of SREBP, increased FAS expression, and thus elevated TG levels (H.Y. Lim and R.B., unpublished data). In addition, this effect is also observed in mammalian hepatocytes where TOR function is required for SREBP activation (Li et al., 2010) , and it has been proposed that TOR serves as an important fork in the road of diabetic insulin resistance separating gluconeogenesis from lipogenesis (Li et al., 2010; Laplante and Sabatini, 2010) . Collectively, these data support the idea that TOR is required to mediate HFDinduced obesity and ensuing (cardiac) organ defects via multiple mechanisms. Interestingly, reducing or blocking fat accumulation mimics the protective effects of lowered insulin-TOR signaling under a HFD. However, it remains to be determined what it is about the accumulating fat that is detrimental to an organism: is the fat itself or a side effect of its accumulation that is causing metabolic and physiological dysregulation?
Our data indicate that heart dysfunction due to the HFD treatment is the result of autonomous changes within the heart, as evidenced by the increased cardiac TG levels; and cardiaconly reduction of insulin-TOR signaling protects the heart from dysfunction and fat accumulation. Importantly, our findings show that inhibition of insulin-TOR signaling or ensuing fat accumulation in the heart itself can significantly prevent cardiac dysfunction despite the presence of elevated systemic TG levels. In addition, HFD-induced obesity also influences heart function via the adipose tissue, since blocking insulin-TOR function in the adipose can also prevent the HFD obesity heart phenotypes. Thus, nonautonomous crosstalk factors, which may include hormones or metabolites, also contribute to HFDinduced heart dysfunction. The Drosophila model will help to understand the basis of such crosstalk.
The fact that flies become obese on a HFD has important implications on its own. Theories for the increased frequency and appearance of obesity include the thrifty gene hypothesis, which tries to understand why the incidence of obesity may be increasing despite its deleterious effects. These ideas state that recent evolutionary selection pressure on people experiencing frequent famines concentrated genetic variants that increased the ability to provide sufficient nutrients to an organism in times of lean, but also predisposed to obesity in times of plenty. Alternatively, the potential for HFD-induced obesity may have arisen early in evolution, perhaps independently of external selection pressure, via deregulation of metabolic responses in multicellular organisms. In this report, we provide evidence to suggest that the capacity for HFD-induced obesity and its associated complications is likely evolutionarily ancient and inherent to core nutrient-sensing pathways, a property that manifests itself upon exposure to dietary extremes resulting in a homeostatic imbalance that exceeds the normal dynamic range. The discovery of these HFD-induced obesity phenotypes in the Drosophila genetic model will permit a detailed dissection of obesity phenotypes, especially with regard to the cardiac lipotoxicity effects (and possibly mimicking aspects of diabetic cardiomyopathy). In particular, we can now attempt to understand the various contributions of insulin resistance, fat accumulation, and fatty acid oxidation to the HFD-induced obesity phenotypes, including timing requirements. In summary, the advent of the Drosophila HFD-induced obesity model opens up many new horizons to study deregulated processes and diseases of chronic lipid excess.
EXPERIMENTAL PROCEDURES Fly Stocks
We obtained w 1118 flies from Bloomington's Stock Center and used these as wild-type controls. We used multiple drivers for each tissue type. For driving expression ubiquitously, we used arm-Gal4 (Bloomington); in the FB we used the lsp-Gal4 (Cherbas et al., 2003) and the DCG-Gal4 (provided by Jon Graff and J. Suh); for the heart we used GMH5 (Wessells et al., 2004) and Hand-Gal4 (Han et al., 2006) . We found similar trends for corresponding drivers for each tissue. S6K DN (Mary Stewart), and UAS-d4EBP (Miron et al., 2001 ), UAS-FAS-RNAi (Vienna RNAi stock center), and UAS-Bmm (Gronke et al., 2005) were used. UAS-TOR TED and UAS-TSC1-2 were a donation (by Tom Neufeld). The TOR mutants are from Luong et al. (2006) . To test a negative effector of the insulin signaling pathway, we used UAS-FOXO (Wessells et al., 2004) . All flies were maintained on NF source made from a combination of yeast, corn starch, and molasses. HFD was made by mixing either 3%, 7%, 15%, or 30% coconut oil to the food in a weight-to-volume ratio with the NF.
Heart Assays
For a detailed analysis of the cardiac contractions it is necessary to surgically expose the fly's heart in order to make it accessible for high-resolution video microscopy (Vogler and Ocorr 2009) . In this analysis we used the previously published heart assay and analysis (Ocorr et al., 2007a (Ocorr et al., , 2007b (Ocorr et al., , 2007c Fink et al., 2009 ). In brief, dissections to expose the fly's heart within the abdomen were kept in oxygenated saline, and high-speed digital movies were taken and then analyzed for heart rate, arrhythmia, contractility, FS, etc. (Ocorr et al., 2007a (Ocorr et al., , 2007b (Ocorr et al., , 2007c Fink et al., 2009) .
HFD Feeding Regime
Bottles of flies were emptied and dated; then 5 days after emptying the vial, all flies were taken and placed in a new vial of NF and aged 5 more days. This population was then spilt into two populations, one on NF and one on the designated concentration of HFD, for either 2, 5, or 10 days. We used 30% HFD for 5 days for the majority of the experiments, since it gave strong and reproducible phenotypes.
Statistical Analysis
All statistical analysis was done using Student's t tests, and the analysis was performed using GraphPad Prism version 5.00 for Windows, (GraphPad Software, San Diego California USA, http://www.graphpad.com/). Additional methods are in the Supplemental Information available online.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, nine movies, Supplemental Experimental Procedures, and Supplemental References and can be found with this article at doi:10.1016/j.cmet.2010.09.014.
